Abstract
Background Hyperbaric oxygen therapy (HBOT) is a treatment modality in which a subject breathes 100% O2 under increased atmospheric pressure, typically 2-3 Atmospheres Absolute (ATA) in mono-or multiplace chambers. HBOT is provided in a variety of clinical settings by providers with varying levels of expertise. It is an important advanced therapy in the treatment of at least fourteen documented ailments.
Objective To study indications, contraindications, and some side effects of hyperbaric oxygen in a group of children with special needs.
Methodology Data for this study were collected from a sample of purposefully selected 100 (69 male+31 female) patients with special needs from a center in Cairo (age range: 72-120 months) to address the aim of the study by the use of different tools: 1. Cases’ parents’ interview form. 2. Full medical history, examination, and investigations. 3. Employing some clinical tests such as tympanometry as well as modified Teed and HAM-A Scores to quantify MEB and anxiety side effects of HBOT. 4. Analysis of data. 5. Suggestions for future improvement of HBOT side effects identification and management.
Results 59% of patients were underweight, 61% stunted, and 58% microcephalic who generally lived in high crowding index environments. They are treated with HBOT and other therapies for LD (38%), CP (36%), ASD (20%), ADHD (4%), and Wounds (2%) and had 2203 sessions in 24 months. For middle ear condition, tympanometry showed that 78 patients had Type A (5 Type AD & 6 Type AS), 6 Type B & 4 Type C. M-Teed score showed that 56% had grade 0, 24% grade 1, 10% grade 2, 3% grade 3, 1% grade 4, and 6% grade 5. For claustrophobia, the Anxiety Severity HAM-A score showed that only 2% had moderate to severe symptoms. 47% of parents were satisfied with the treatments, 35% neutral, and 18% dissatisfied.
Conclusion HBOT remains among the safest therapies used today, especially in the pediatric population with special needs even though there are a few contraindications and side effects associated with it. It is both its primary and secondary effects that result in its benefits as well as side effects. Even though they were found to be infrequent and mild, providers need to be able to identify, understand, and quantify these potential side effects such as MEB and claustrophobia for prevention, management, and informed consent. One of the most common side effects identified in the peer-reviewed literature is MEB. It is typically mild and self-limited. Patient instruction on middle ear clearing, daily monitoring with an otoscopic examination, and appropriate compression rates are important to its prevention. Claustrophobia or confinement anxiety in monoplace chambers is another side effect of HBOT but it is generally mild and anxiety is easily controlled with sedation before treatments so that individuals may continue to receive daily HBOT. Preventive measures with adequate patient history, patient education, reassurance, and coaching are the most effective means of anticipating episodes of claustrophobia and treating them effectively before HBOT.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by The Scientific Ethics Committee of Ain Shams University (Faculty of Postgraduate Studies of Childhood).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: The present study was financially supported solely by the author.
Conflicts of Interest: The author declares no conflicts of interest.
Institutional Review Board Statement: The study was conducted according to the guidelines and approved by The Scientific Ethics Committee of the Department of Medical Studies for Children, the Faculty of Postgraduate Studies of Childhood, and the Ain Shams University.
Informed Consent Statement: The author reviewed and agreed to the published version of the manuscript.
Data Availability Statement: The data that support the findings of this study are available on request from the corresponding author.
Data Availability
All data produced in the present work are contained in the manuscript
List of Abbreviations
- ADHD
- attention-deficit hyperactive disorder
- AGE
- arterial gas embolism
- ASD
- autism spectrum disorder
- ATA
- atmospheres absolute
- ATP
- adenosine triphosphates
- CNS
- central nervous system
- CO
- Carbon monoxide
- CO2
- Carbon dioxide
- COPD
- chronic obstructive pulmonary disease
- CP
- cerebral palsy
- DBP
- diastolic blood pressure
- DM
- Diabetes mellitus
- EF
- ejection fraction
- ET
- Eustachian tube
- HAM-A
- Hamilton Anxiety Score
- HBO2
- Hyperbaric oxygen
- HBOT
- hyperbaric oxygen therapy
- IGF-1
- insulin-like growth factor
- LD
- Learning disability
- MEB
- middle ear barotrauma
- NO
- nitric oxide
- O2
- Oxygen molecule
- ONOO-
- peroxynitrite
- PaO2
- partial pressure of oxygen in arterial blood
- PBT
- pulmonary barotrauma
- pO2
- partial pressure of oxygen
- PTX
- pneumothorax
- RBC
- Red blood cell
- ROS
- reactive oxygen species
- SBP
- systolic blood pressure
- TM
- tympanic membrane
- VEGF
- vascular endothelial growth factor
- UHMS
- The Undersea and Hyperbaric Medical Society
